| Line Item | 2024-02-02 | Y/Y |
|---|---|---|
| Revenue | $7.44B | -3.4% |
| Cost of Revenue | $6.57B | -3.6% |
| R&D Expense | $4.0M | +300.0% |
| SG&A Expense | $373.0M | -0.3% |
| Operating Income | $741.0M | +47.9% |
| Pre-tax Income | $620.0M | +65.3% |
| Income Tax | $143.0M | +98.6% |
| Net Income | $477.0M | +59.0% |
| EPS (Basic) | $8.98 |
| Line Item | 2024-02-02 | Y/Y |
|---|---|---|
| Cash & Equivalents | $94.0M | -13.8% |
| Accounts Receivable | $914.0M | -2.4% |
| Inventory | $3.0M | -95.8% |
| Current Assets | $1.13B | -5.5% |
| Total Assets | $5.31B | -4.1% |
| Current Liabilities | $1.16B | +2.8% |
| Long-term Debt | $2.10B | -11.6% |
| Line Item | 2024-02-02 | Y/Y |
|---|---|---|
| Operating Cash Flow | $396.0M | -25.6% |
| Capital Expenditures | $27.0M | +8.0% |
| Investing Cash Flow | $314.0M | +972.2% |
| Financing Cash Flow | -$725.0M | -47.1% |
| Free Cash Flow | $369.0M | -27.2% |
| +65.7% |
| EPS (Diluted) | $8.88 | +65.1% |
| Stockholders' Equity |
| $1.78B |
| +5.4% |